Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
Sell
40
KNBWY Quote, Financials, Valuation and Earnings
Last price:
$14.48
Seasonality move
:
-5.6%
Day range:
$14.38 - $14.48
52-week range:
$12.25 - $16.25
Dividend yield:
3.33%
P/E ratio:
16.07x
P/S ratio:
0.80x
P/B ratio:
1.59x
Volume:
46.1K
Avg. volume:
30.2K
1-year change:
5%
Market cap:
$11.7B
Revenue:
$15.5B
EPS (TTM):
$0.90
Analysts' Opinion
-
Consensus RatingKirin Holdings has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $16.60, Kirin Holdings has an estimated upside of 14.64% from its current price of $14.48.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $16.60 representing 100% downside risk from its current price of $14.48.
Fair Value
-
According to the consensus of 1 analyst, Kirin Holdings has 14.64% upside to fair value with a price target of $16.60 per share.
KNBWY vs. S&P 500
-
Over the past 5 trading days, Kirin Holdings has underperformed the S&P 500 by -0.82% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Kirin Holdings does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Kirin Holdings revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Kirin Holdings reported revenues of $3.6B.
Earnings Growth
-
Kirin Holdings earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Kirin Holdings reported earnings per share of $0.20.
Enterprise value:
19.6B
EV / Invested capital:
1.21x
Price / LTM sales:
0.80x
EV / EBIT:
13.82x
EV / Revenue:
1.33x
PEG ratio (5yr expected):
0.29x
EV / Free cash flow:
47.64x
Price / Operating cash flow:
28.45x
Enterprise value / EBITDA:
9.64x
Gross Profit (TTM):
$6.8B
Return On Assets:
3.61%
Net Income Margin (TTM):
4.95%
Return On Equity:
7.57%
Return On Invested Capital:
4.91%
Operating Margin:
5.68%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $15B | $15.1B | $14.7B | $3.4B | $3.6B | |
| Gross Profit | $6.8B | $6.8B | $6.8B | $1.5B | $1.7B | |
| Operating Income | $800.6M | $1.2B | $989.6M | $207.7M | $203.3M | |
| EBITDA | $2B | $2.2B | $2B | $457.4M | $437.6M | |
| Diluted EPS | $0.91 | $1.14 | $0.90 | $0.22 | $0.20 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $7.3B | $6.9B | $6.1B | $6.5B | $6.4B | |
| Total Assets | $22.1B | $20.6B | $18.5B | $19.9B | $21.8B | |
| Current Liabilities | $6.3B | $4.9B | $4.2B | $4.6B | $5.6B | |
| Total Liabilities | $11.8B | $10.8B | $9.3B | $10.2B | $12.5B | |
| Total Equity | $10.2B | $9.8B | $9.2B | $9.6B | $9.3B | |
| Total Debt | $6.1B | $5.2B | $4.2B | $5B | $6.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.2B | $1.4B | $1.3B | $268.7M | $67.2M | |
| Cash From Investing | $220.3M | -$1.8B | -$1.1B | -$440.3M | -$297.8M | |
| Cash From Financing | -$1.7B | $555.3M | -$398M | $234.1M | $382M | |
| Free Cash Flow | $394M | $659.8M | $412.1M | $120.5M | -$175.2M | |
KNBWY
Sector
Market Cap
$11.7B
$258.9M
Price % of 52-Week High
89.11%
75.55%
Dividend Yield
3.33%
0%
Shareholder Yield
-0.1%
2.89%
1-Year Price Total Return
5%
-11.52%
Beta (5-Year)
0.153
0.392
Dividend yield:
3.33%
Annualized payout:
$0.48
Payout ratio:
53.42%
Growth streak:
1 years
Technicals
8-day SMA
Buy
Level
$14.41
200-day SMA
Buy
Level
$14.15
Bollinger Bands (100)
Buy
Level
12.88 - 14.72
Chaikin Money Flow
Sell
Level
-7M
20-day SMA
Sell
Level
$14.59
Relative Strength Index (RSI14)
Sell
Level
48.20
ADX Line
Buy
Level
11.17
Williams %R
Neutral
Level
-60.6383
50-day SMA
Sell
Level
$14.53
MACD (12, 26)
Sell
Level
-0.07
25-day Aroon Oscillator
Sell
Level
-36
On Balance Volume
Neutral
Level
3M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.0072)
Sell
CA Score
(Annual)
Level (-0.5322)
Buy
Beneish M-Score
(Annual)
Level (-2.534)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-0.1204)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Kirin is the second-largest brewer in Japan with a 28% market share. It holds a top share in the happoshu (low-malt beer) and new genre (no-malt beer) categories. Apart from beer, it also operates a wide range of alcoholic and soft beverage products in Japan. It has made several acquisitions, including Lion Nathan and National Foods in Australia, the second-largest Brazilian brewer Schincariol and Myanmar’s biggest brewer over the past decade. It sold the businesses in Brazil and Myanmar in 2017 and 2023, respectively. In 2023, the company made a tender offer to bring Fancl on as a wholly owned subsidiary. Its revenue accounts for roughly 5% of Kirin’s total sales. Its overseas business, which includes alcoholic and nonalcoholic beverages, represents about 40% of the group’s sales.
Stock Forecast FAQ
In the current month, KNBWY has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The KNBWY average analyst price target in the past 3 months is $16.60.
-
Where Will Kirin Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that Kirin Holdings share price will rise to $16.60 per share over the next 12 months.
-
What Do Analysts Say About Kirin Holdings?
Analysts are divided on their view about Kirin Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Kirin Holdings is a Sell and believe this share price will drop from its current level to $16.60.
-
What Is Kirin Holdings's Price Target?
The price target for Kirin Holdings over the next 1-year time period is forecast to be $16.60 according to 1 Wall Street analyst, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is KNBWY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Kirin Holdings is a Hold. 1 of 1 analysts rates the stock a Hold at this time.
-
How Can I Buy Shares Of KNBWY?
You can purchase shares of Kirin Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Kirin Holdings shares.
-
What Is The Kirin Holdings Share Price Today?
Kirin Holdings was last trading at $14.48 per share. This represents the most recent stock quote for Kirin Holdings. Yesterday, Kirin Holdings closed at $14.48 per share.
-
How To Buy Kirin Holdings Stock Online?
In order to purchase Kirin Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
